title: Oral administration of polyphenolic compounds from cognac decreases ADP-induced platelet aggregation and reduces chronotropic effect of isoprenaline in rats.
abstract: This study sought to evaluate whether consumption of polyphenol extract from Cognac (CPC) modulates platelet activation and cardiovascular reactivity in rats. Male Wistar rats were treated daily for 4 weeks by intra-gastric gavage receiving CPC at 80 mg/kg/day or vehicle (5 % glucose). Platelet adhesion and aggregation in response to different activators were assessed. Cardiac and vascular reactivity in response to various agonists as well as NO measurement by electron paramagnetic resonance technique were investigated in isolated heart and thoracic aorta. Oral administration of CPC decreased platelet aggregation induced by ADP but not by collagen. CPC did not affect adhesion to collagen. The chronotropic but not the inotropic response to isoprenaline was reduced without alteration of NO production in hearts from CPC-treated rats. CPC treatment did not affect ex vivo relaxation to acetylcholine nor NO content of rat aorta. CPC did not significantly alter the response to phenylephrine in aorta despite the participation of endothelial vasoconstrictor products. In summary, chronic treatment with CPC has no impact on ex vivo vascular and cardiac reactivity; however, it reduced heart work and platelet aggregation. These data suggest the existence of compounds in Cognac that may decrease the risk of coronary thrombosis and protect against some cardiac diseases.
authors: CNRS UMR 6214-INSERM 771, Faculté de Médecine, Angers, France.
authors: N
authors: N
authors: Carusio
authors: R
authors: R
authors: Wangensteen
authors: A
authors: A
authors: Filippelli
authors: R
authors: R
authors: Andriantsitohaina
mesh_terms: D000244:Adenosine Diphosphate / Q000037:antagonists & inhibitors* / Q000494:pharmacology*; D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000434:Alcoholic Beverages / Q000032:analysis*; D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects; D002448:Cell Adhesion / Q000187:drug effects; D003094:Collagen / Q000378:metabolism; D004578:Electron Spin Resonance Spectroscopy; D005419:Flavonoids / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects*; D007545:Isoproterenol / Q000037:antagonists & inhibitors* / Q000494:pharmacology*; D008297:Male; D009206:Myocardium / Q000378:metabolism; D009569:Nitric Oxide / Q000502:physiology; D010636:Phenols / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects*; D059808:Polyphenols; D051381:Rats; D017208:Rats, Wistar
chemical_list: D000318:Adrenergic beta-Agonists; D005419:Flavonoids; D010636:Phenols; D059808:Polyphenols; D009569:Nitric Oxide; D000244:Adenosine Diphosphate; D003094:Collagen; D007545:Isoproterenol